Cumulus Neuroscience Email Format
Biotechnology ResearchNorthern Ireland, United Kingdom11-50 Employees
Cumulus Neuroscience is a biotechnology research company based in Belfast, Northern Ireland. It has developed an integrated platform that combines physiological data with digital biomarker information to support neuroscience clinical trials. The platform is designed to deliver data and insights that can make CNS trials faster, more robust, and more cost-efficient, addressing unmet needs in neurodegeneration and psychiatry. The company serves pharmaceutical and biotech sponsors conducting CNS-focused research, providing data to inform trial design and evaluation. In January 2026, Cumulus Neuroscience announced the appointment of Ricardo Sáinz Fuertes, MD, as board chair.